Jonathan Mahlowitz
Keine laufenden Positionen mehr
Karriereverlauf von Jonathan Mahlowitz
Ehemalige bekannte Positionen von Jonathan Mahlowitz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RADIUS HEALTH, INC. | General Counsel | 01.11.2019 | - |
Unternehmenssekretär | - | 01.07.2020 | |
FLEXION THERAPEUTICS, INC. | General Counsel | - | - |
Ausbildung von Jonathan Mahlowitz
Boston College Law School | Graduate Degree |
Rochester Christian University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
General Counsel | 2 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Flexion Therapeutics, Inc.
Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Jonathan Mahlowitz
- Erfahrung